wegovy

Swissmedic, the Swiss drugs regulator, has issued a warning against the purchase of drugs from unreliable sources, particularly from abroad, following reports of hospitalizations linked to counterfeit injectables of the diabetes medication Ozempic, Swissinfo reports. Counterfeit Ozempic and Health...

On Tuesday, the European Union’s drug regulator expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including those produced by Novo Nordisk (NASDAQ:NVO). The probe now encompasses about 150 reported cases...

As the world watches tech titans Elon Musk and Mark Zuckerberg prepare for an unexpected boxing match, Musk’s slimmed-down physique has caught attention. This transformation is attributed to his use of Wegovy, a semaglutide medication used for chronic weight management, Fast Company reports....

A new clinical trial has shown that Mounjaro, a diabetes drug similar to Ozempic and Wegovy, could be a game-changer in the field of weight loss, Insider reports. Mounjaro, developed by Eli Lilly and Co. (NYSE:LLY), was approved for treating type 2 diabetes in May 2022. The latest data suggests...

Danish pharma giant Novo Nordisk A/S (NYSE:NVO) is due to announce results from a late-stage trial, dubbed SELECT, that evaluates its semaglutide, sold under the brand name Wegovy, for the reduction of cardiovascular events in overweight or obese non-diabetic patients with prior cardiovascular...

Novo Nordisk A/S (NYSE: NVO) reported Q1 FY23 sales of DKK 53.37 billion, up 27% Y/Y (+25% on constant currency). Earlier this month, the Denmark-based company significantly raised its full-year operating profit and sales expectations due to strong demand for Wegovy, an...